期刊文献+

下调WT1基因对K562细胞血管内皮生长因子表达的影响 被引量:1

Effect to the expression of VEGF in K562 cells by down-regulation of WT1
原文传递
导出
摘要 目的 探讨WT1基因沉默对人类白血病细胞血管内皮生长因子(VEGF)表达的影响.方法 将已构建的WT1小发夹RNA(shRNA)质粒载体转染入K562细胞,流式细胞术检测转染效率并对转染细胞进行分选,实时荧光定量PCR检测细胞转染前后WT1及VEGF基因mRNA的表达变化,用ELISA检测转染前后细胞培养液中VEGF浓度的变化.结果 转染48h,WT1shRNA质粒转入K562细胞,转染效率为(65±4.5)%,通过流式细胞术分选,可以得到纯度达98%以上的WT1shRNA阳性细胞,转染后的K562细胞WT1及VEGF基因mRNA表达较转染前及对照组均明显降低(P<0.05),转染后48、72h细胞培养液中VEGF的含量较对照组明显降低(P<0.05).结论 WT1干扰质粒在体外可以抑制白血病细胞株VEGF的表达,提示WT1基因可能通过上调VEGF基因的表达而参与白血病的血管新生. Objective To investigate the effect to the expression of VEGF in human leukemic cell line by WT1gene silencing. Methods K562 cells were transfected with WT1shRNA Plasmid.Transfection efficiency was detected by flow cytometIy,and the succeed transfered cells Were sorted.WT1 and VEGF mRNA variation were measured by fluorescence RT-PCR. VEGF concentrations in the cell growth medium were detected by ELISA.Results 48 hours after transfection,the transfection efficiency was 65%±4.5%.WT1shRNA positive cells were sorted by flow cytometry.Both the mRNA level of WT1 and VEGF and VEGF concentrations in cell growth medium were significantly decreased than the control group. Conclusion WT1 gene silence can down-regulate the expression of VEGF in K562 cells which suggest that WT1 gene may take part in leukemia angiogenesis through up-regulation of VEGF.
出处 《肿瘤研究与临床》 CAS 2008年第3期152-154,157,共4页 Cancer Research and Clinic
基金 山西省自然基金资助项目(20051102)
  • 相关文献

参考文献9

  • 1Scharnhorst V,van-der-Eb AJ,Jochemsen AG. WT1 proteins functions in growth and differentiation[J].Gene,2001,(02):141-161.doi:10.1016/S0378-1119(01)00593-5.
  • 2肖志坚.血管新生与血液系统恶性疾病[J].国外医学(输血及血液学分册),2001,24(3):190-193. 被引量:9
  • 3Olszewski M,Muang W,Chou PM. Wilms tumorl (WT1) gene hematopoiesis:surrogate marker of cell proliferation as a possible mechanism of action?[J].Cytotherapy,2005,(01):57-61.doi:10.1080/14653240510018046.
  • 4Bairey O,Boycov O,Kaganovsky E. All three receptor for vascular endothelial growth factor (VEGF) are expressed on B-chronic lymphocytic leukemia (CLL) cells[J].Leukemia Research,2004,(03):221-222.doi:10.1016/S0145-2126(03)00256-X.
  • 5Bellamy WT,Richter L,Frufiger Y. Expression of vascular endothelial growth factor and its receptors in hematopoietic malignancies[J].Cancer Research,1999,(03):728-733.
  • 6Lundberg LG,Lerner R,Sundelin P. Bone marrow in polycythemia vera,chronic myelocytie leukemia,and myelofibrosis has an increased vascularity[J].American Journal of Pathology,2000,(01):15-19.
  • 7段卫明,陈子兴.WT1介导的转录调控通路与白血病[J].中国实验血液学杂志,2002,10(4):366-370. 被引量:5
  • 8白波,王宏伟,徐永群,杨黑女,乔振华.荧光定量PCR检测急性白血病患者外周血WT1基因表达及其临床意义[J].中国实验血液学杂志,2005,13(4):610-614. 被引量:7
  • 9Hanson J,Gorman J,Reese J. Regulation of vascular endothelial growth factor,VEGF,gene promotor by the tumor suppressor,WT1[J].Frontiers in Bioscience,2007,(22):2279-2290.doi:10.2741/2230.

二级参考文献39

  • 1Call KM, Glaser T, Ito CY, et al. Isolation and characterization of a zinc finger polypeptide gene at the human chromosome 11 Wilms' tumor locus. Cell, 1990; 60:509-520.
  • 2Drummond IA, Rupprecht, HD, Rohwer-Nutter P, et al. DNA recognition by splicing variants of the Wilms ' tumor suppressor,WT1. Mol Cell Bol, 1994; 14:3800 -3809.
  • 3Miwa H, Beran M, Saunders GF, et al. Expression of the Wilms tumor gene ( WT1 ) in human leukemias. Leukemia, 1992; 6: 405-409.
  • 4Inoue K, Sugiyama H, Ogawa H, et al. WT1 as a new prognostic factor and a new marker for the detection of minmial residual disease in acute leukemia. Blood, 1994; 84:3071 -3079.
  • 5Kreuzer KA, Saborowski A, Lupberger J, et al. Fluorescent 5'-exonclease assay for the absolute quantification of Wilms' tumor gene ( WT1 ) mRNA: implications for monitoring human leukemias. Br J Haematol, 2001; 114:313 -318.
  • 6Cilloni D, Gottardi E, De-Micheli D, et al. Quantitative assessment of WT1 expression by real time quantitative PCR may be a useful tool for monitoring minimal residual disease in acute leukemia patients. Leukemia, 2002; 16: 2115 - 2121.
  • 7Baird PN, Simmons PI. Expression of the Wilms ' tumor gene (WT1) in normal hemopoiesis. Exp Hematol, 1997; 25: 312-320.
  • 8Kusumoto S, Murohashi I, Bessho M, et al. The importance of WT1 gene expression in the detection of minimal residual disease. A comparison of WT1 AML/MTG8 transcripts. Rinsho Ketsueki,1999; 40:511 -514.
  • 9Inoue K, Ogawa H, Yamagami T, et al. Long-term follow-up of minimal residual disease in leukemia patients by monitoring WT1 (Wilms tumor gene) expression levels. Blood, 1996; 88: 2267 -2278.
  • 10Trka J, Kalinova M, Hrusak O, et al. Real-time quantitative PCR detection of WT1 gene expression in children with AML: prognostic significance, correlation with disease status and residual disease detection by flow cytometry. Leukemia, 2002; 16:1381 -1389.

共引文献17

同被引文献11

  • 1Kramarzova K, Boublikova L, Stary J, et al. Evaluation of WT1 expression in bone marrow(BM) vs. peripheral blood (PB) samples of children with acute myeloid leukemia-impact on minimal residual disease detection[J]. Leukemia, 2013,27 (5) : 1194-1196.
  • 2Perez-Atayde AR.Spectrum of tumor angiogenesis in the bone marrow of children with acute lymphoblaatic leukemia [J]. Am J Pathol, 1997,150(3) :815-821.
  • 3Sekiya M, Adachi M, Hinoda Y, et al. Downregialation of Wilms, tumor gene(WT1) during myelomonoetie differentiation in HL-60 cell[J]. Blood, 1994,83(7):1876-1882.
  • 4Cilloni D.Early prediction of treatment outcome in aeute myeloid leukemia by measurement of WT1 transcript levels in peripheral blood samples collected after chemotherapy[J]. Haematologica, 2008,93(6) :921-924.
  • 5Sennino B,Ishiguro-Oonuma T, Wei Y. Suppression of tumor invasion and metastasis by concurrent inhibition of c-Met and VEGF signaling in pancreatic neuroendoerine tumors [J ]. Cancer Discov, 2012,2(3) :270.
  • 6Toi M, Matsumoto T, Bando H. Vascular endothelial growth factor: its prognostic, predictive, and therapeutic implications [J]. Lancet Oncol, 2001,2(11) :667-673.
  • 7Kondo S, Asano M, Matsuo K, et al.Vascular endothelial growth factor/vascular permeability factor is detectable in the sera of tumor bearing mice and cancer patients[J]. Biochim Biophys Acta, 1994,1221(2) :211- 214.
  • 8Hanson J, Gorman J, Reese J, et al . Regulation of vascular endothelial growth factor, VEGF, gene promoter by the tumor suppressor, WT1[J]. Front Biosci, 2007, 12 (22) :2279-2290.
  • 9Iranparast S, Assarehzadegan MA, Heike Y, et al. Wilms, tumor gene (WT1) expression correlates with vascular epithelial growth factor(VEGF)in newly acute leukemia patients undergoing chemotherapy [J]. Asian Pac J Caner Prey, 2014,15(21) :9217 -9223.
  • 10McCarty G, Awad O, DM L. WT1 protein directly regulates expression of vascular endothelial growth factor and is a me diator of tumor response to hypoxia[J]. J Biol Chem, 2011, 286(51) :43634 -43643.

引证文献1

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部